Prognostic Impact and Clinicopathological Correlation of CD133 and ALDH1 Expression in Invasive Breast Cancer

PURPOSE: CD133 and aldehyde dehydrogenase 1 (ALDH1) expression are reliable poor-prognosis markers associated with the presence of adverse biomarkers and subtypes of breast cancer. The aim of our study was to investigate and compare the clinical impact of CD133 and ALDH1 expression in invasive breas...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Sung Jeep, Kim, Yong Seok, Jang, Eun Duok, Seo, Kyung Jin, Kim, Jeong Soo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Breast Cancer Society 2015
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4705086/
https://www.ncbi.nlm.nih.gov/pubmed/26770241
http://dx.doi.org/10.4048/jbc.2015.18.4.347

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4705086/
https://www.ncbi.nlm.nih.gov/pubmed/26770241
http://dx.doi.org/10.4048/jbc.2015.18.4.347

Ejemplares similares